Non-Hodgkin lymphoma statistics
- 12,783 people in the UK were diagnosed with non-Hodgkin lymphoma (all subtypes combined) in 2011.
- There were 4,676 deaths from non-Hodgkin lymphoma (all subtypes combined) in the UK in 2012.
- 63% of adult non-Hodgkin lymphoma (all subtypes combined) patients (62% of men and 64% of women) diagnosed in 2010-2011 in England and Wales are predicted to survive ten or more years.
- 6% of non-Hodgkin lymphoma (all subtypes combined) cases each year in the UK are linked to major lifestyle and other risk factors.
Stats, info and publications
The latest statistics available for non-Hodgkin lymphoma (all subtypes combined) are; incidence 2011, mortality 2012 and survival 2010-2011. Find out why these are the latest statistics available.
The ICD codes for non-Hodgkin lymphoma (all subtypes combined) are ICD-10 C82-C85.
Non-Hodgkin lymphoma statistics by subtype are provided for the Haematological Malignancy Research Network (HMRN) region. HMRN covers a population of 3.6 million and is set within the former adjacent UK Cancer Networks of Yorkshire and the Humber & Yorkshire Coast England. While HMRN may not be fully representative of the country as a whole due to variation in local healthcare provision standards and policies, the population does have a similar socio-demographic profile to the UK.
Survival statistics give an overall picture of survival and (unless otherwise stated) include all adults (15-99) diagnosed, at all ages, stages and co-morbidities. The survival time experienced by an individual patient may be much higher or lower, depending on specific patient and tumour characteristics. If you are a patient, please see our CancerHelp UK pages.
Specific questions and answers about some of Cancer Research UK's statistics and information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of the statistics are also available.
We would like to acknowledge the essential work of the cancer registries in the United Kingdom and Ireland Association of Cancer Registries, without which there would be no data.
We would also like to thank the following people for their kind help and expert advice: Dr Alex Smith and Professor Eve Roman, Haematological Malignancy Research Network (HMRN, funded by Leukaemia & Lymphoma Research); Dr Hamish Ross, National Cancer Intelligence Network (NCIN) haematology Site-Specific Clinical Reference Group (which is hosted by Public Health England); Dr Steven Oliver, Knowledge and Intelligence Team (Northern & Yorkshire) on behalf of the NCIN; Dr Russell Patmore, Queens Centre for Oncology and Haematology, Castle Hill Hospital; and Dr Debra Howell, HMRN. However, the contents are entirely the responsibility of Cancer Research UK.
Question about cancer? Contact our information nurse team